Expert second opinions for cardiomyopathy. Dual-physician Heart Team review with triple risk scoring. Results in 24 hours.
Cardiomyopathy encompasses diseases of the heart muscle that impair its ability to pump blood effectively. If you are facing a decision about cardiomyopathy, an independent Heart Team second opinion can confirm whether surgery is the right choice and identify alternatives. WhiteGloveMD delivers dual-physician review with STS, EuroSCORE II, and AATS risk scoring in 24 hours. Get an independent second opinion →
Cardiomyopathy encompasses diseases of the heart muscle that impair its ability to pump blood effectively. Dilated cardiomyopathy (DCM) involves ventricular enlargement and weakening, hypertrophic cardiomyopathy (HCM) involves abnormal thickening, and restrictive cardiomyopathy involves stiffening of the heart wall.
Each type of cardiomyopathy has different treatment algorithms and surgical options. HCM may benefit from septal myectomy, DCM may require LVAD or transplant evaluation, and the diagnosis itself may change management. Genetic testing implications for family members add another layer of complexity.
Surgery for cardiomyopathy depends on symptom severity, imaging findings, and risk profile. Guidelines from the AHA/ACC define specific thresholds, but many patients fall into gray zones where a second opinion meaningfully changes the recommendation. Each type of cardiomyopathy has different treatment algorithms and surgical options. HCM may benefit from septal myectomy, DCM may require LVAD or transplant evaluation, and the diagnosis itself may change management. Genetic testing implications for family members add another layer of complexity.
Operative mortality for cardiomyopathy-related cardiac surgery is calculated using validated models including STS PROM, EuroSCORE II, and AATS. Individual risk depends on age, comorbidities, frailty, ejection fraction, and surgeon/center volume. Our free calculator at whiteglovemd.com/tools/risk-calculator estimates your specific risk across all three models in real time.
Yes. Studies show that 30-40% of expert cardiac surgery second opinions change the original treatment plan — sometimes by recommending less-invasive alternatives, sometimes by clarifying that watchful waiting is safer. WhiteGloveMD pairs a cardiac surgeon and cardiologist with our Clintelligence multi-agent AI pipeline to deliver an independent review in 24 hours, starting at $500.
The optimal treatment for cardiomyopathy depends on anatomy, comorbidities, age, and personal goals. Accurate diagnosis and classification. A Heart Team review evaluates every viable option — including transcatheter approaches, repair vs replacement, and surgeon/center matching — rather than defaulting to a single recommendation.
WhiteGloveMD delivers a dual-physician, AI-augmented second opinion in 24 hours. Starting at $500.